Thalomid (Celgene Corporation)
Welcome to the PulseAid listing for the Thalomid drug offered from Celgene Corporation. This Decreased Immunologically Active Molecule Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Celgene Corporation |
| NON-PROPRIETARY NAME: | Thalidomide |
| SUBSTANCE NAME: | THALIDOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Immunologically Active Molecule Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-06-20 |
| END MARKETING DATE: | 0000-00-00 |
Thalomid HUMAN PRESCRIPTION DRUG Details:
| Item Description | Thalomid from Celgene Corporation |
| LABELER NAME: | Celgene Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2003-06-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59572-205_882e87f8-07f5-4876-af6b-e2bb4e5b2f62 |
| PRODUCT NDC: | 59572-205 |
| APPLICATION NUMBER: | NDA020785 |
Other THALIDOMIDE Pharmaceutical Manufacturers / Labelers:
